{
  "generated_at": "2026-02-05T09:49:26Z",
  "company_id": "immatics",
  "company_name": "Immatics",
  "asset_count": 8,
  "change_count": 73,
  "assets": [
    {
      "asset_id": 48,
      "asset_name": "IMA203CD8",
      "aliases": [
        "IMA203CD8"
      ],
      "indications": [
        {
          "indication": "Gynecologic cancers; other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Gynecologic cancers; other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Gynecologic cancers; other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Gynecologic cancers; other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Gynecologic cancers; other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Gynecologic cancers; other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Gynecologic cancers; other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Gynecologic cancers; other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Gynecologic cancers; other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        }
      ]
    },
    {
      "asset_id": 51,
      "asset_name": "IMA401",
      "aliases": [
        "IMA401"
      ],
      "indications": [
        {
          "indication": "HNSCC, sqNSCLC, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "HNSCC, sqNSCLC, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "HNSCC, sqNSCLC, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "HNSCC, sqNSCLC, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "HNSCC, sqNSCLC, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "HNSCC, sqNSCLC, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "HNSCC, sqNSCLC, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "HNSCC, sqNSCLC, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "HNSCC, sqNSCLC, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        }
      ]
    },
    {
      "asset_id": 49,
      "asset_name": "IMA402",
      "aliases": [
        "IMA402"
      ],
      "indications": [
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        }
      ]
    },
    {
      "asset_id": 50,
      "asset_name": "IMA402 + ICI",
      "aliases": [
        "ICI",
        "IMA402",
        "IMA402 + ICI"
      ],
      "indications": [
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers (combo)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers (combo)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers (combo)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers (combo)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers (combo)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers (combo)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers (combo)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers (combo)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Melanoma, gynecologic cancers, other solid cancers (combo)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        }
      ]
    },
    {
      "asset_id": 52,
      "asset_name": "Undisclosed bispecific",
      "aliases": [
        "Undisclosed bispecific"
      ],
      "indications": [
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        }
      ]
    },
    {
      "asset_id": 53,
      "asset_name": "Undisclosed cell therapy",
      "aliases": [
        "Undisclosed cell therapy"
      ],
      "indications": [
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Undisclosed",
          "stage": "Preclinical",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        }
      ]
    },
    {
      "asset_id": 46,
      "asset_name": "anzu-cel",
      "aliases": [
        "anzu tresgene autoleucel",
        "anzu-cel (anzutresgene autoleucel IMA203)",
        "anzu-cel (anzutresgene autoleucel)",
        "anzu-cel (IMA203)",
        "anzu-tresgene autoleucel",
        "anzutresgene autoleucel",
        "IMA203",
        "IMA203CD8",
        "nivolumab",
        "Opdivo",
        "Taxol"
      ],
      "indications": [
        {
          "indication": "2L melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "2L melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "2L melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "2L melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "2L melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "2L melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "2L melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "2L melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (in combination with mRNA-4203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (in combination with mRNA-4203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (in combination with mRNA-4203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (in combination with mRNA-4203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (in combination with mRNA-4203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (in combination with mRNA-4203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (in combination with mRNA-4203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (in combination with mRNA-4203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Uveal melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Uveal melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Uveal melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Uveal melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Uveal melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Uveal melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Uveal melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Uveal melanoma",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        }
      ]
    },
    {
      "asset_id": 47,
      "asset_name": "mRNA-4203",
      "aliases": [],
      "indications": [
        {
          "indication": "Solid cancers (combo with anzu-cel / IMA203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (combo with anzu-cel / IMA203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (combo with anzu-cel / IMA203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (combo with anzu-cel / IMA203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (combo with anzu-cel / IMA203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (combo with anzu-cel / IMA203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (combo with anzu-cel / IMA203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        },
        {
          "indication": "Solid cancers (combo with anzu-cel / IMA203)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology",
          "as_of_date": null
        }
      ]
    }
  ]
}